{"entity":{"id":"4fe8d3ec-3487-5b04-877d-c8ddaf0718be","name":"ORBIMED ADVISORS LLC","type":"Person","kind":"person","jurisdiction":"US","identifier":"sec:0001055951","risk":"MED","flags":[]},"identity":{"linked_records":[],"also_known_in":[]},"ownership":{"direct_owners":[],"holdings":[{"role":"director","share":null,"asset":{"id":"6d317465-e113-5fee-9632-915c2579af2d","name":"Disc Medicine, Inc.","type":"Company","kind":"company"}},{"role":"director","share":null,"asset":{"id":"6d317465-e113-5fee-9632-915c2579af2d","name":"Disc Medicine, Inc.","type":"Company","kind":"company"}},{"role":"director","share":null,"asset":{"id":"6d317465-e113-5fee-9632-915c2579af2d","name":"Disc Medicine, Inc.","type":"Company","kind":"company"}},{"role":"10% owner","share":null,"asset":{"id":"6af50270-7dd4-5262-8756-e6fc9afb96e3","name":"MBX Biosciences, Inc.","type":"Company","kind":"company"}},{"role":"director","share":null,"asset":{"id":"36003c1e-2a7d-5ea2-a95f-e01c345a874c","name":"Sionna Therapeutics, Inc.","type":"Company","kind":"company"}},{"role":"director","share":null,"asset":{"id":"36003c1e-2a7d-5ea2-a95f-e01c345a874c","name":"Sionna Therapeutics, Inc.","type":"Company","kind":"company"}},{"role":"10% owner","share":null,"asset":{"id":"ff58a3f1-31a1-5645-b8cf-4af0e8a2099d","name":"Traws Pharma, Inc.","type":"Company","kind":"company"}},{"role":"10% owner","share":null,"asset":{"id":"3797b803-565f-56ce-9606-f58967c79f6d","name":"Passage BIO, Inc.","type":"Company","kind":"company"}},{"role":"10% owner","share":null,"asset":{"id":"3797b803-565f-56ce-9606-f58967c79f6d","name":"Passage BIO, Inc.","type":"Company","kind":"company"}}],"ubo_chain":[]},"risk":{"level":"MED","flags":[],"note":"Risk is a layer-1 signal (offshore-layering / connectivity heuristics) — an investigative lead, not a determination."},"sources":[{"registry":"sec_edgar","source_url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001055951"}],"source":"corpus"}